1) diclofenac potassium tablet
双氯酚酸钾片
1.
OBJECTIVE:To study the relative bioavailablity and bioequivalence of diclofenac potassium granule and diclofenac potassium tablet.
目的 :进行双氯酚酸钾颗粒与双氯酚酸钾片单剂双交叉生物等效性研究。
2) Diclofenac potassium
双氯酚酸钾
1.
OBJECTIVE:To investigate the characteristics of drug release and the factors affecting the in vitro dissolubility of diclofenac potassium double-layer tablets(DPD).
目的 :考察双氯酚酸钾双层片的体外释放特征及其影响因素。
2.
Plasma diclofenac potassium concentration of 8 male healthy young volunteers after a self alternative single oral dose (50 mg) of diclofenac potassium capsules and tablets were detected by the HPLC method.
8名健康男性志愿者自身交叉单剂量口服双氯酚酸钾 5 0mg胶囊剂和片剂 ,采用反相高效液相色谱法测定经时过程血药浓度 。
3) diclofenac potassium granule
双氯酚酸钾颗粒
1.
OBJECTIVE:To study the relative bioavailablity and bioequivalence of diclofenac potassium granule and diclofenac potassium tablet.
目的 :进行双氯酚酸钾颗粒与双氯酚酸钾片单剂双交叉生物等效性研究。
5) diclofenac
双氯酚酸
1.
Inhabition to orthodontic tooth movement in rats between diclofenac and rofecoxib.;
双氯酚酸和罗非考昔抑制鼠牙移动的效果比较
2.
Aim To establish an HPLC method for the evaluation of cytochrome P450 2C9 activity using diclofenac as the probe compound in vitro.
目的建立一种快速、高效的以双氯酚酸作为探针药物评价细胞色素P4502C9(CYP2C9)酶活性的高效液相色谱-紫外检测方法。
6) diclofenac potassium
双氯芬酸钾
1.
Affecting factor of the diclofenac potassium release in vitro from hydroxypopylmethyl cell ulose tablets;
双氯芬酸钾羟丙基甲基纤维素骨架片体外释药的影响因素
2.
Factorial design and contour overlay plot in the development of buccoadhesive diclofenac potassium tablets: formulation optimization and validation;
因子设计-重叠等高线图法优化双氯芬酸钾口腔黏附片处方
3.
Influence of different factors on the release properties of diclofenac potassium from HPMC matrix tablets in vitro;
双氯芬酸钾HPMC骨架片体外释药影响因素研究
补充资料：氯锇酸钾
分子式： K2[OsCl6]
CAS号：
性质：深棕色结晶。溶于水、盐酸,不溶于乙醇。用20％浓度的盐酸溶解四氯化锇,并加少量乙醇,移入烧瓶,加热回流,浓缩冷却,加盐酸溶解结晶,加过量15％的氯化钾溶液反应生成。作试剂。
CAS号：
性质：深棕色结晶。溶于水、盐酸,不溶于乙醇。用20％浓度的盐酸溶解四氯化锇,并加少量乙醇,移入烧瓶,加热回流,浓缩冷却,加盐酸溶解结晶,加过量15％的氯化钾溶液反应生成。作试剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条